Article

Some of the best links we picked up around the internet

A first-in-human, phase I trial tested intrathecal delivery of CRISPR-Cas9-edited, allogeneic IL-13Rα2 CAR-T cells in five people with recurrent...

Researchers in Japan have developed CRISPR-Cas3 genome editing to target the TTR gene in transthyretin amyloidosis, achieving substantial protein...

Researchers in Japan have developed a CRISPR-Cas-based system to edit epigenetic marks in mouse sperm, enabling direct investigation of whether DNA...

Researchers have built a CRISPR-based screening system that directly reads RNA splicing outcomes, using it to uncover medically relevant regulators of...

Some of the best links we picked up around the internet

nChroma Bio has received regulatory clearance in Hong Kong to initiate a Phase 1/2 clinical trial of its lead candidate CRMA-1001, marking the first...

Structural analysis of Cas5 from Moraxella bovoculi reveals that this protein functions equally well as a monomer or a dimer for RNA processing, but...